Non‐steroidal mineralocorticoid receptor antagonist vs selective aldosterone antagonist
Doubling serum creatinine · proteinuric chronic kidney disease
Non‐steroidal mineralocorticoid receptor antagonist showed no clear difference in doubling serum creatinine compared with selective aldosterone antagonist (low certainty).
1 finding from 1 review
- Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic… 2020 · Cochrane Headline outcomes onlyRR 0.8 [0.03, 19.51]1 study · 1055 participantsLow